Under the direction of a new CEO, Oxford GlycoSciences plc released a plan Thursday to reduce its burn rate and improve performance by dividing its business into three separate units. (BioWorld Today)
Under the direction of a new CEO, Oxford GlycoSciences plc released a plan Thursday to reduce its burn rate and improve performance by dividing its business into three separate units. (BioWorld Today)
SILVER SPRING, Md. - An FDA advisory panel provided late-stage lung cancer patients with a ray of hope Tuesday when it leaned toward recommending approval of Iressa, an epidermal growth factor receptor tyrosine kinase inhibitor. (BioWorld Today)
SILVER SPRING, Md. - An FDA advisory panel provided late-stage lung cancer patients with a ray of hope Tuesday when it leaned toward recommending approval of Iressa, an epidermal growth factor receptor tyrosine kinase inhibitor. (BioWorld Today)
